Target Name: CABIN1
NCBI ID: G23523
Review Report on CABIN1 Target / Biomarker Content of Review Report on CABIN1 Target / Biomarker
CABIN1
Other Name(s): KB-318B8.7 | Calcineurin-binding protein cabin-1 (isoform a) | PPP3IN | CAIN | CABIN1 variant 2 | Calcineurin binding protein 1, transcript variant 3 | Calcineurin binding protein cabin 1 | Calcineurin binding protein 1, transcript variant 2 | Calcineurin inhibitor | Calcineurin-binding protein cabin-1 (isoform b) | Calcineurin-binding protein cabin-1 | CABIN1 variant 3 | calcineurin inhibitor | KIAA0330 | calcineurin binding protein 1 | calcineurin binding protein cabin 1 | CABIN_HUMAN

Discovering The Role of CABIN1 in Disease

CABIN1 (KB-318B8.7) is a protein that is expressed in various tissues of the human body, including the brain, heart, lungs, and liver. It is a member of the letter family and belongs to the transcription factor silencing gene (Transcription factor-mediated gene silencing) family.

CABIN1 plays an important biological function in organisms. It plays a key role in multiple physiological processes, including cell proliferation, differentiation, and tumor formation. In certain diseases, CABIN1 expression levels change, which may contribute to the onset and progression of these diseases. Therefore, it is important to study the role of CABIN1 in disease.

CABIN1 was first discovered by American scientists in 1997. They found that CABIN1 is expressed in a variety of cancers. In addition, they also found that the expression level of CABIN1 was related to the aggressiveness and growth rate of tumors.

In recent years, researchers have studied CABIN1 intensively to understand its role in disease. They found that CABIN1 is related to the occurrence and development of tumors in many diseases. For example, CABIN1 is associated with the progression and invasion of cancers including lung, colon, and breast cancer.

In addition, researchers have found that CABIN1 can be used as a therapeutic target in certain diseases. For example, they found that CABIN1 can inhibit tumor growth by inhibiting its expression. In addition, they found that CABIN1 is associated with drugs that can be used to treat certain cancers.

CABIN1 is a very important protein that plays important biological functions in organisms. Researchers are deeply studying CABIN1's role in disease and looking for the possibility of CABIN1 as a therapeutic target. With further research, CABIN1 may become an important drug target and provide new ways to treat many diseases.

Protein Name: Calcineurin Binding Protein 1

Functions: May be required for replication-independent chromatin assembly. May serve as a negative regulator of T-cell receptor (TCR) signaling via inhibition of calcineurin. Inhibition of activated calcineurin is dependent on both PKC and calcium signals. Acts as a negative regulator of p53/TP53 by keeping p53 in an inactive state on chromatin at promoters of a subset of it's target genes

The "CABIN1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CABIN1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CABLES1 | CABLES2 | CABP1 | CABP2 | CABP4 | CABP5 | CABP7 | CABS1 | CABYR | CACFD1 | CACHD1 | CACNA1A | CACNA1B | CACNA1C | CACNA1C-AS4 | CACNA1C-IT2 | CACNA1C-IT3 | CACNA1D | CACNA1E | CACNA1F | CACNA1G | CACNA1G-AS1 | CACNA1H | CACNA1I | CACNA1S | CACNA2D1 | CACNA2D1-AS1 | CACNA2D2 | CACNA2D3 | CACNA2D4 | CACNB1 | CACNB2 | CACNB3 | CACNB4 | CACNG1 | CACNG2 | CACNG2-DT | CACNG3 | CACNG4 | CACNG5 | CACNG6 | CACNG7 | CACNG8 | CACTIN | CACTIN-AS1 | CACUL1 | CACYBP | CAD | CADM1 | CADM2 | CADM3 | CADM3-AS1 | CADM4 | CADPS | CADPS2 | CAGE1 | CAHM | CALB1 | CALB2 | CALCA | CALCB | Calcium channel | Calcium release-activated channel (CRAC) | Calcium-activated chloride channel regulators | Calcium-Activated K(Ca) Potassium Channel | CALCOCO1 | CALCOCO2 | CALCR | CALCRL | CALCRL-AS1 | CALD1 | CALHM1 | CALHM2 | CALHM3 | CALHM4 | CALHM5 | CALHM6 | CALM1 | CALM2 | CALM2P1 | CALM2P2 | CALM3 | CALML3 | CALML3-AS1 | CALML4 | CALML5 | CALML6 | Calmodulin | CALN1 | Calpain | Calpain-13 | Calprotectin | CALR | CALR3 | CALU | CALY | CAMK1 | CAMK1D | CAMK1G | CAMK2A